Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Pathol ; 26(2): 186-98, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25990815

ABSTRACT

Maturation of the auditory pathway is dependent on the central nervous system myelination and it can be affected by pathologies such as neonatal hypoxic ischemic (HI) encephalopathy. Our aim was to evaluate the functional integrity of the auditory pathway and to visualize, by histological and cellular methods, the damage to the brainstem using a neonatal rat model of HI brain injury. To carry out this morphofunctional evaluation, we studied the effects of the administration of the antioxidants nicotine, melatonin, resveratrol and docosahexaenoic acid after hypoxia-ischemia on the inferior colliculus and the auditory pathway. We found that the integrity of the auditory pathway in the brainstem was altered as a consequence of the HI insult. Thus, the auditory brainstem response (ABR) showed increased I-V and III-V wave latencies. At a histological level, HI altered the morphology of the inferior colliculus neurons, astrocytes and oligodendricytes, and at a molecular level, the mitochondria membrane potential and integrity was altered during the first hours after the HI and reactive oxygen species (ROS) activity is increased 12 h after the injury in the brainstem. Following antioxidant treatment, ABR interpeak latency intervals were restored and the body and brain weight was recovered as well as the morphology of the inferior colliculus that was similar to the control group. Our results support the hypothesis that antioxidant treatments have a protective effect on the functional changes of the auditory pathway and on the morphological damage which occurs after HI insult.


Subject(s)
Antioxidants/pharmacology , Evoked Potentials, Auditory, Brain Stem/drug effects , Hypoxia-Ischemia, Brain/drug therapy , Inferior Colliculi/drug effects , Neuroprotective Agents/pharmacology , Animals , Animals, Newborn , Astrocytes/drug effects , Astrocytes/pathology , Astrocytes/physiology , Body Weight , Disease Models, Animal , Docosahexaenoic Acids/pharmacology , Evoked Potentials, Auditory, Brain Stem/physiology , Gliosis/drug therapy , Gliosis/pathology , Gliosis/physiopathology , Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/physiopathology , Inferior Colliculi/growth & development , Inferior Colliculi/pathology , Inferior Colliculi/physiopathology , Melatonin/pharmacology , Neurons/drug effects , Neurons/pathology , Neurons/physiology , Nicotine/pharmacology , Oligodendroglia/drug effects , Oligodendroglia/pathology , Oligodendroglia/physiology , Organ Size , Random Allocation , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Resveratrol , Stilbenes/pharmacology
2.
PLoS One ; 10(11): e0142424, 2015.
Article in English | MEDLINE | ID: mdl-26544861

ABSTRACT

Despite advances in neonatal care, hypoxic-ischemic brain injury is still a serious clinical problem, which is responsible for many cases of perinatal mortality, cerebral palsy, motor impairment and cognitive deficits. Resveratrol, a natural polyphenol with important anti-oxidant and anti-inflammatory properties, is present in grapevines, peanuts and pomegranates. The aim of the present work was to evaluate the possible neuroprotective effect of resveratrol when administered before or immediately after a hypoxic-ischemic brain event in neonatal rats by analyzing brain damage, the mitochondrial status and long-term cognitive impairment. Our results indicate that pretreatment with resveratrol protects against brain damage, reducing infarct volume, preserving myelination and minimizing the astroglial reactive response. Moreover its neuroprotective effect was found to be long lasting, as behavioral outcomes were significantly improved at adulthood. We speculate that one of the mechanisms for this neuroprotection may be related to the maintenance of the mitochondrial inner membrane integrity and potential, and to the reduction of reactive oxygen species. Curiously, none of these protective features was observed when resveratrol was administered immediately after hypoxia-ischemia.


Subject(s)
Brain Injuries/prevention & control , Cognition Disorders/prevention & control , Hypoxia-Ischemia, Brain/drug therapy , Neuroprotective Agents/pharmacology , Stilbenes/pharmacology , Animals , Animals, Newborn , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/pathology , Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Brain/pathology , Brain Injuries/pathology , Brain Injuries/psychology , Cognition Disorders/psychology , Disease Models, Animal , Female , Hypoxia-Ischemia, Brain/pathology , Hypoxia-Ischemia, Brain/psychology , Male , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/metabolism , Myelin Basic Protein/metabolism , Neuroprotective Agents/administration & dosage , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Resveratrol , Stilbenes/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...